Navigation Links
Excalibur International Marine (49% Owned by EFT BioTech Holdings) Completes Inaugural Passenger Crossing of Taiwan Strait
Date:6/30/2009

CITY OF INDUSTRY, Calif. and HONG KONG, June 30 /PRNewswire-FirstCall/ -- EFT BioTech Holdings, Inc. (Pink Sheets: EFTB), announced today that Excalibur's Ocean LaLa has successfully completed its inaugural Taiwan Strait passenger voyage which has been highlighted in multiple news articles and internet news sites, including the Taiwan Sun, and the Qatar Tribune. The article states:

"A Taiwan company launched a cruise service with China on Sunday, making it the first such cross-strait service in 60 years.

"With a band playing and dragon dance performing on shore, the 2,292-tonne Ocean LaLa set sail from the Taichung Harbour for Xiamen, China, carrying 179 passengers and 23 crew.

"The voyage across the Taiwan Strait takes only four-and-a-half-hours, but it took Taiwan and China 60 years to ease tension and for Taipei to agree to lift the ban on sea links with the mainland."

The Excalibur International Marine Corp, operator of the cruise service, said that in the initial stage, the Taichung-Xianmen cruise is an irregular service chartered by travel agencies.

"Eventually it will become a regular cruise service going not only to Xiamen, but also to other Chinese ports like Fuzhou and Shanghai," said Han Chih-yang, Excalibur's deputy.

"We are full of confidence for the future of cross-strait tourism, so we are seeking to buy two larger ships for launching regular cross-strait service," he said.

Jack Qin, the President and CEO of EFT BioTech Holdings, stated, "We are excited to be recognized by the world press and this article shows that people are truly interested in this much needed passenger and cargo service."

About EFT BioTech Holdings, Inc.

EFT BioTech Holdings, Inc. is a Nevada holding company which conducts its business through its wholly-owned subsidiary, EFT Bio
'/>"/>

SOURCE EFT BioTech Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Excalibur - Transforming Biotech Deals can Still be Achieved
2. Excalibur Celebrates PIramed Sale With Substantial Cash Return to Investors
3. Galichia Heart Hospital Partners with Mobile Surgery International to Develop Wichita-based Center of Excellence with Global Convenience(TM)
4. International Products Corp.s Lab Offers Filter Membrane Compatibility and Studies
5. Cord Blood America Continues International Expansion
6. PAREXEL International to Present at the Wachovia Equity Conference
7. BioEnergy International, LLC Announces Formation of Myriant Technologies LLC
8. Biostar Pharmaceuticals, Inc. Retains HC International, Inc. to Implement Investor Relations Program
9. NeoStem, Inc. Appoints Financial Expert with Broad International Experience to the Board of Directors and to Serve as Chairman of the Companys Audit Committee
10. Yongye Biotechnology International Receives License to Manufacture Products
11. Cynvec to Present at the 11th Annual Shanghai International Forum on Biotechnology and Pharmaceutical Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... LONDON , December 23, 2014 ... Review Algeria , out today and available for free ... the actors driving change and growth in the sector today. ... has scored notable successes has been in developing a homegrown ... 70 percent local production still remains some way off. A ...
(Date:12/22/2014)... Md. , Dec. 22, 2014 /PRNewswire/ ... SYN), a developer of pathogen-specific therapies for ... on protecting the microbiome, today announced positive ... Phase 1a clinical trial of SYN-004, the ... prevention of Clostridium difficile (C. difficile) ...
(Date:12/22/2014)... The American Journal of ... research, reviews and editorials addressing developments and pathways ... published a provocative article exploring the role of ... potential treatment of prostate cancer. , The ... the possibility that there could be a connection ...
(Date:12/19/2014)... 19, 2014 BioPlus Specialty Pharmacy ... announces the promotion of Nick Maroulis, Pharm.D. to the ... Services. , In this position, Dr. Maroulis will ... managing the directors of our multi-site pharmacies as the ... 1997 and during that time he has served in ...
Breaking Biology Technology:PharmaBoardroom Releases New Algeria Pharmaceuticals Report 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2
... SAN DIEGO, March 4, 2011 Volcano Corporation (Nasdaq: ... of precision guided therapy tools designed to enhance the ... announced today that it received clearance to market the ... will introduce the device at the 20th PCI Live ...
... SACRAMENTO, Calif., March 3, 2011 Claims that Assembly ... preserve a physical therapist,s license made by the author ... than a smokescreen contends the California Physical Therapy Association ... world. AB 783 amends sections of the ...
... (ASX: HZL; OTCQX: HLTZY) announced that it has entered ... ("the Trout Group"), a leading New York-based investor relations ... investor relations services for Healthzone for an initial engagement ... current clients, the Trout Group provides investor relations and ...
Cached Biology Technology:Volcano Announces the Introduction of the Eagle Eye® Platinum Digital IVUS Catheter at the 20th PCI Live Demonstration Course in Kurashiki 2Volcano Announces the Introduction of the Eagle Eye® Platinum Digital IVUS Catheter at the 20th PCI Live Demonstration Course in Kurashiki 3False Claims by Supporters Swirl Around Hayashi Bill 2Healthzone Limited Engages The Trout Group for Investor Relations Services 2
(Date:12/17/2014)... , Dec. 15, 2014  HITLAB SM ... Clinical Practices (GCP) audit to confirm its adherence ... regulations. This accomplishment enables HITLAB to conduct regulated ... the highest principles for patient safety and research ... global healthcare access, quality, and delivery with innovative ...
(Date:12/17/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/9zq33j/global_chemical ) ... Chemical Sensor Market 2015-2019" report to their ... One major trend upcoming in this ... in biomedical applications. Chemical sensors help in recording ... during surgical procedures. The Global Chemical Sensor market ...
(Date:12/15/2014)... 12, 2014 Research and Markets ... the "Global Facial Recognition Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 Facial recognition is ... Facial recognition system measures the overall facial feature ... mouth, and the distance between eyes. Facial recognition ...
Breaking Biology News(10 mins):HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
... Beverly Hills, Calif. and Washington DC (ASRM Annual Meeting) ... patients undergoing in-vitro fertilization (IVF) is improved when doctors ... embryos to the point where the endometrium is most ... the 63rd Annual Meeting of the American Society for ...
... Delaware has been named a regional research participant in ... health ever conducted in the United States. The ... Health, will follow an estimated 100,000 children in communities ... years of age. It will seek information to prevent ...
... help us think, in addition to its well-known role ... cells. We hypothesize that blood actively ... principle investigator in the McGovern Institute for Brain Research ... of Neurophysiology. Many lines of evidence suggest that blood ...
Cached Biology News:In-vitro fertilization improved with 3-D/4-D-guided embryo transfer and new placement target 2In-vitro fertilization improved with 3-D/4-D-guided embryo transfer and new placement target 3UD named a regional research participant in National Children’s Study 2MIT: blood may help us think 2
Human VEGF R Phycoerythrin Sampler (Cl 89106, 49560, 54733)...
... Beagle Serum • Beagle serum is ... over one year of age Available Anticoagulants: ... Heparin (Na) N-06: K2EDTA N-08: ... N-03: Alsevers N-05: ACD ...
... Kit is designed to purify double-stranded DNA (dsDNA) ... and PCR. The process is simple and fast. ... g can be efficiently purified and concentrated. The ... is bound to the Microfilter Cartridge in the ...
This BioSolution package is excellent for doing fluorescence thermal melt experiments on nucleic acids, studies involving biomolecular interactions, protein folding experiments, and more!...
Biology Products: